The Australian this morning claimed API is the likely winner of a 300 million contract with Alphapharm.The deal will add 10% to there ebit.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025